tiprankstipranks
Advertisement
Advertisement

PCROHLC Stock Latest News

Ro – Weekly Recap
Private CompaniesRo – Weekly Recap
8d ago
ROHLC
Ro Highlights Telehealth-Driven Strategy in Obesity Care
PremiumPrivate Companies
Ro Highlights Telehealth-Driven Strategy in Obesity Care
12d ago
ROHLC
Ro Emphasizes Digital-First Strategy in Obesity Care Expansion
PremiumPrivate Companies
Ro Emphasizes Digital-First Strategy in Obesity Care Expansion
12d ago
ROHLC
Ro – Weekly Recap
PremiumPrivate Companies
Ro – Weekly Recap
29d ago
ROHLC
Ro Cuts Ro Body Membership Pricing to Drive GLP-1 Patient Growth
PremiumPrivate Companies
Ro Cuts Ro Body Membership Pricing to Drive GLP-1 Patient Growth
1M ago
ROHLC
Ro Cuts Ro Body Membership Pricing to Spur GLP-1 Program Growth
PremiumPrivate CompaniesRo Cuts Ro Body Membership Pricing to Spur GLP-1 Program Growth
1M ago
ROHLC
Ro Highlights AI Triage Tool Aimed at Improving Patient Response Times
Premium
Private Companies
Ro Highlights AI Triage Tool Aimed at Improving Patient Response Times
1M ago
ROHLC
Ro Highlights AI-Powered Side-Effect Triage Tool and Faster Patient Response Times
Premium
Private Companies
Ro Highlights AI-Powered Side-Effect Triage Tool and Faster Patient Response Times
1M ago
ROHLC
Ro Highlights Structural Shifts in Healthcare Driven by GLP-1 Demand
PremiumPrivate Companies
Ro Highlights Structural Shifts in Healthcare Driven by GLP-1 Demand
1M ago
ROHLC
Ro Positions Around GLP-1 Demand and Evolving Patient-Centered Care
PremiumPrivate Companies
Ro Positions Around GLP-1 Demand and Evolving Patient-Centered Care
1M ago
ROHLC
Ro Expands GLP-1 Offering With Addition of Eli Lilly’s Foundayo Pill
PremiumPrivate Companies
Ro Expands GLP-1 Offering With Addition of Eli Lilly’s Foundayo Pill
2M ago
ROHLC
Ro Expands GLP-1 Portfolio With Addition of Eli Lilly’s Foundayo Pill
PremiumPrivate Companies
Ro Expands GLP-1 Portfolio With Addition of Eli Lilly’s Foundayo Pill
2M ago
ROHLC
Ro Adds Lilly’s Oral GLP-1 Foundayo to Expand Obesity Treatment Platform
PremiumPrivate CompaniesRo Adds Lilly’s Oral GLP-1 Foundayo to Expand Obesity Treatment Platform
2M ago
ROHLC
Ro Expands GLP-1 Weight-Loss Offering With Nationwide Launch of Zepbound KwikPen
Premium
Private Companies
Ro Expands GLP-1 Weight-Loss Offering With Nationwide Launch of Zepbound KwikPen
2M ago
ROHLC
Ro Targets GLP-1 Market With Wegovy Pricing and Membership Savings
Premium
Private Companies
Ro Targets GLP-1 Market With Wegovy Pricing and Membership Savings
2M ago
ROHLC
Ro Expands Wegovy Pricing Discounts and Ties Savings to Upcoming Membership Program
PremiumPrivate Companies
Ro Expands Wegovy Pricing Discounts and Ties Savings to Upcoming Membership Program
2M ago
ROHLC
Ro Deepens Novo Nordisk Partnership With Lower-Cost Wegovy Plans and Expanded GLP-1 Offering
PremiumPrivate Companies
Ro Deepens Novo Nordisk Partnership With Lower-Cost Wegovy Plans and Expanded GLP-1 Offering
2M ago
ROHLC
Ro Expands GLP-1 Access With Wegovy Pricing and Membership Savings Focus
PremiumPrivate Companies
Ro Expands GLP-1 Access With Wegovy Pricing and Membership Savings Focus
2M ago
ROHLC
Ro Highlights GLP-1 Patient Outcomes and Lifestyle Impact in Obesity Care
PremiumPrivate Companies
Ro Highlights GLP-1 Patient Outcomes and Lifestyle Impact in Obesity Care
3M ago
ROHLC
Ro Highlights GLP-1 Patient Outcomes and Lifestyle Impact
PremiumPrivate CompaniesRo Highlights GLP-1 Patient Outcomes and Lifestyle Impact
3M ago
ROHLC
Ro Emphasizes Lifestyle Outcomes in GLP-1 Obesity Care Campaign
Premium
Private Companies
Ro Emphasizes Lifestyle Outcomes in GLP-1 Obesity Care Campaign
3M ago
ROHLC
Ro Launches First Super Bowl Campaign to Scale GLP-1 Weight-Loss Business
Premium
Private Companies
Ro Launches First Super Bowl Campaign to Scale GLP-1 Weight-Loss Business
4M ago
ROHLC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >